You’ve accepted all cookies. You can change your cookie settings at any time.
The Consortium brings together 16 leading organisations, spanning the NHS, regulators, and leading third sector and charitable organisations
The National Institute for Biological Standards and Control will carry out independent testing in the UK for any potential COVID-19 vaccines.
The vaccine has been approved after meeting the required safety, quality and effectiveness standards.
The Access Consortium regulatory authorities have pledged our collective support in countering the COVID-19 global pandemic.
Women receiving treatment for epilepsy are being urged to discuss with a healthcare professional the right treatment for them if they anticipate becoming pregnant even sometime in the future, following a safety review.
The Medicines and Healthcare products Regulatory Agency (MHRA) today, 1 January 2021, formally starts the Innovative Licensing and Access Pathway (ILAP).
The new vaccine has been approved after meeting the required safety, quality and effectiveness standards.
An application for exceptional use of a COVID-19 rapid test, to be used by members of the public, has today been approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
MHRA Chief Executive Dr June Raine explains the process behind the Agency's approval of the Pfizer/BioNTech vaccine
Government has published a report highlighting the work and achievements of its Vaccines Taskforce (VTF).
The first COVID-19 vaccine for the UK, developed by Pfizer/BioNTech, has today been given approval for use following a thorough review carried out by the Medicines and Healthcare products Regulatory Agency (MHRA).
The safety of the public will always come first.
Safety is our watch word.
Women using modafinil are being warned of an increased risk of birth defects associated with modafinil use during pregnancy.
We are reviewing the risks and benefits of the acne medicine, isotretinoin. In particular whether some of the possible psychiatric and sexual side effects continue after treatment has been stopped.
The Yellow Card scheme is the UK’s system for reporting suspected side effects to medicines and adverse events with medical devices run by the Medicines and Healthcare products Regulatory Agency (MHRA).
The MHRA’s Enforcement Group, working in collaboration with German law enforcement partners, has helped to dismantle a global criminal network involved in the illegal sale of medicines online.
Users of Safe and Sound Infrared Ear Thermometers are being urged by the MHRA to check their product code and lot number due to a voluntary product recall of specific lots initiated by the company due to a fault.
US-licensed flu vaccine (Flublok) to be used as part of the UK’s 2020/21 seasonal flu programme
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.